Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Sanofi-Aventis Canada Inc.
02 15Bayer Inc.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Brand Name : ZALTRAP
Patent Number : 2519875
Filing Date : 2004-06-04
Strength per Unit : 100 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Brand Name : EYLEA
Patent Number : 2376379
Filing Date : 2000-05-23
Strength per Unit : 2mg / 0.05 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVITREAL
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Brand Name : ZALTRAP
Patent Number : 2376379
Filing Date : 2000-05-23
Strength per Unit : 100 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Brand Name : ZALTRAP
Patent Number : 2586735
Filing Date : 2005-12-02
Strength per Unit : 100 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Brand Name : ZALTRAP
Patent Number : 2376379
Filing Date : 2000-05-23
Strength per Unit : 200 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Brand Name : ZALTRAP
Patent Number : 2519875
Filing Date : 2004-06-04
Strength per Unit : 200 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Brand Name : ZALTRAP
Patent Number : 2586735
Filing Date : 2005-12-02
Strength per Unit : 200 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2027-06-14
Date Granted : 2015-03-17
Brand Name : EYLEA
Patent Number : 2654510
Filing Date : 2007-06-14
Strength per Unit : 2mg / 0.05 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVITREAL
Patent Expiration Date : 2027-06-14
Date Granted : 2015-03-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 1935-12-10
Date Granted : 2023-08-22
Brand Name : EYLEA HD
Patent Number : 2970315
Filing Date : 2015-12-10
Strength per Unit : 8mg / 0.07mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVITREAL
Patent Expiration Date : 1935-12-10
Date Granted : 2023-08-22
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 1936-12-01
Date Granted : 2021-12-28
Brand Name : EYLEA HD
Patent Number : 3007276
Filing Date : 2016-12-01
Strength per Unit : 8mg / 0.07mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVITREAL
Patent Expiration Date : 1936-12-01
Date Granted : 2021-12-28
